89bio Presents New Analysis of Data from Phase 2 ENTRIGUE
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG......
Cytokinetics Presents Positive Results From Cohort 4 of
Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive......
The RealReal Announces Inducement Grants under Nasdaq
SAN FRANCISCO, March 03, 2023 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ: REAL) – the world’s largest online marketplace for authenticated, resale......
Praxis Precision Medicines to Present at Upcoming Investor
BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating......
Impel Pharmaceuticals to Participate in Upcoming Investor
SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing......
Cumulus Media’s Westwood One Presents Audio Coverage of
Coverage Includes 23 Games between Saturday, March 4th and Sunday, March 12th, 2023......
TaskUs to Participate in the Morgan Stanley Technology,
NEW BRAUNFELS, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and......
Daseke Announces Chief Operating Officer Transition
Specialized Segment leader and transportation industry veteran, Scott Hoppe, to become EVP and COO effective June 1, 2023......
Cidara Therapeutics Announces Pricing of Public Offerings
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics......
Morphic to Present at TD Cowen 43rd Annual Health Care
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral......